An Observational Study for Appraisal of Clinical Outcome and Risk of Mother-to-child SARS-CoV-2 Transmission in Neonates Provided the Benefits of Mothers' Own Milk
Overview
Authors
Affiliations
This observational study done during April-December 2020 at a tertiary-care hospital in Haryana (India) enrolled 152 SARS-CoV-2-exposed neonates. Among them, 150 neonates had perinatal SARS-CoV-2 exposure and 2 neonates had late postnatal exposure. Stable infant-mother dyads were roomed-in with precautions to support breastfeeding. Nasopharyngeal swabs collected from neonates were tested for SARS-CoV-2 by reverse transcriptase-polymerase chain reaction (RT-PCR) test. There was a high incidence of prematurity (23%), low birth weight (31%), intrauterine fetal distress (16%), perinatal asphyxia (6%), admission to neonatal intensive care unit (24%), and mortality (1.3%) among neonates with perinatal SARS-CoV-2 exposure. In this sub-group, 20 neonates tested positive for SARS-CoV-2 in nasopharyngeal swab sample(s). A recent official publication by the World Health Organization emphasizes that the perinatal SARS-CoV-2-exposed neonates found RT-PCR positive once in upper respiratory (non-sterile) sample must document viral persistence in another non-sterile sample for confirmation of mother-to-child virus transmission. With this approach, only one neonate was confirmed intrapartum transmission. A telephonic follow-up in discharged neonates at 1 month of age or 1 month postexposure recorded them all to be asymptomatic and doing well.Conclusion: Neonates with perinatal SARS-CoV-2 exposure constitute a high-risk group and it is not uncommon to get a positive RT-PCR report in upper respiratory sample(s) from these babies. Majority of them do not demonstrate viral persistence. Clinical outcomes are favorable in breastfed infants roomed-in with their asymptomatic-mild symptomatic SARS-CoV-2-infected mothers following appropriate safety protocols. What is Known: •Neonates with perinatal exposure suffer a high burden of morbidities and mortality. •Still, an uncertainty exists about rooming-in and breastfeeding among neonates born to SARS-CoV-2 positive mothers. What is New: •With the policy of mother-infant rooming-in and supporting breastfeeding, none of the neonate suffered clinical illness compatible with postnatal SARS-CoV-2 transmission and infection. •Around 13% perinatal exposed neonates demonstrated SARS-CoV-2 RNA in nasopharyngeal swab samples but the majority of them did not demonstrate viral persistence.
Asymptomatic viruses detectable in saliva in the first year of life: a narrative review.
Goh M, Joy C, Gillespie A, Soh Q, He F, Sung V Pediatr Res. 2023; 95(2):508-531.
PMID: 38135726 DOI: 10.1038/s41390-023-02952-0.
Morniroli D, Vizzari G, Tosi M, Treglia G, Corsello A, Marchisio P Sci Rep. 2023; 13(1):8813.
PMID: 37258854 PMC: 10230471. DOI: 10.1038/s41598-023-36097-1.
Jeong Y, Kim M Obstet Gynecol Sci. 2023; 66(4):270-289.
PMID: 37194243 PMC: 10375217. DOI: 10.5468/ogs.22323.
Role of the humoral immune response during COVID-19: guilty or not guilty?.
Yaugel-Novoa M, Bourlet T, Paul S Mucosal Immunol. 2022; 15(6):1170-1180.
PMID: 36195658 PMC: 9530436. DOI: 10.1038/s41385-022-00569-w.
The COVID-19 Pandemic and Pregnancy: Impact on Mothers and Newborns.
Twanow J, McCabe C, Ream M Semin Pediatr Neurol. 2022; 42:100977.
PMID: 35868726 PMC: 9122838. DOI: 10.1016/j.spen.2022.100977.